- Cephaeline methyl ether
- Cephaline-o-methyl ether
- Methyl cephaeline
White amorphous powder.
Registry Numbers and Inventories.
Tumorigen; Drug; Mutagen; Human Data; Natural Product; Primary Irritant
Melting point, °C
Solubility in water
Hazards and Protection.
Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.
All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.
Use NIOSH/MSHA approved respirator appropriate for exposure of concern.
Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces.
Turns yellow on exposure to light and heat. Solid and solutions turn yellow on exposure to light or heat. Emetine dihydrochloride darkens on exposure to light.
Strong oxidizing agents.
Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.
Rapid heart rate and abnormally low blood pressure may be seen with large doses or chronic abuse. With therapeutic use - 1. Rapid heart rate and abnormally low blood pressure may be seen with large doses.
Acute ingestion of the fluid extract results in protracted vomiting, abdominal cramps, and profuse diarrhea.
Eye contact causes delayed irritation and superficial corneal injury.
Do not administer additional syrup of ipecac since emesis is the toxic effect. Do not administer a cathartic. Activated charcoal is unlikely to be of use. Treat dehydration with intravenous or oral fluids.
If symptoms develop, move individual away from exposure and into fresh air. If symptoms persist, seek medical attention. If breathing is difficult, administer oxygen. Keep person warm and quiet; seek immediate medical attention.
Remove contaminated clothing. Wash exposed area with soap and water. If symptoms persist, seek medical attention. Launder clothing before reuse.
If symptoms develop, immediately move individual away from exposure and into fresh air. Flush eyes gently with water for at least 15 minutes while holding eyelids apart; seek immediate medical attention.